These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 36189597)
21. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease. Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360 [TBL] [Abstract][Full Text] [Related]
22. 'Alzheimer-like' pathology in a murine model of arterial hypertension. Carnevale D; Lembo G Biochem Soc Trans; 2011 Aug; 39(4):939-44. PubMed ID: 21787327 [TBL] [Abstract][Full Text] [Related]
23. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease. Gomez-Arboledas A; Carvalho K; Balderrama-Gutierrez G; Chu SH; Liang HY; Schartz ND; Selvan P; Petrisko TJ; Pan MA; Mortazavi A; Tenner AJ Acta Neuropathol Commun; 2022 Aug; 10(1):116. PubMed ID: 35978440 [TBL] [Abstract][Full Text] [Related]
24. The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review. Bathini M; Raghushaker CR; Mahato KK Cell Mol Neurobiol; 2022 May; 42(4):955-971. PubMed ID: 33301129 [TBL] [Abstract][Full Text] [Related]
25. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential. Takeda S; Sato N; Ogihara T; Morishita R Front Biosci; 2008 Jan; 13():2253-65. PubMed ID: 17981707 [TBL] [Abstract][Full Text] [Related]
26. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related]
27. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease. Hamm V; Héraud C; Bott JB; Herbeaux K; Strittmatter C; Mathis C; Goutagny R Sci Adv; 2017 Feb; 3(2):e1601068. PubMed ID: 28275722 [TBL] [Abstract][Full Text] [Related]
28. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease. Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease. Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359 [TBL] [Abstract][Full Text] [Related]
33. Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Bartus RT; Dean RL Psychopharmacology (Berl); 2009 Jan; 202(1-3):15-36. PubMed ID: 19011839 [TBL] [Abstract][Full Text] [Related]
34. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584 [TBL] [Abstract][Full Text] [Related]
35. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. Reddy PH CNS Spectr; 2009 Aug; 14(8 Suppl 7):8-13; discussion 16-8. PubMed ID: 19890241 [TBL] [Abstract][Full Text] [Related]
36. Lights on for Autism: Exploring Photobiomodulation as an Effective Therapeutic Option. Hamilton C; Liebert A; Pang V; Magistretti P; Mitrofanis J Neurol Int; 2022 Oct; 14(4):884-893. PubMed ID: 36412693 [TBL] [Abstract][Full Text] [Related]
37. Transcranial photobiomodulation in the management of brain disorders. Montazeri K; Farhadi M; Fekrazad R; Akbarnejad Z; Chaibakhsh S; Mahmoudian S J Photochem Photobiol B; 2021 Aug; 221():112207. PubMed ID: 34119804 [TBL] [Abstract][Full Text] [Related]
38. Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease. Johnstone DM; Moro C; Stone J; Benabid AL; Mitrofanis J Front Neurosci; 2015; 9():500. PubMed ID: 26793049 [TBL] [Abstract][Full Text] [Related]
39. The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease. Yoon G; Shah SA; Ali T; Kim MO Mol Neurobiol; 2018 Aug; 55(8):6673-6686. PubMed ID: 29335844 [TBL] [Abstract][Full Text] [Related]
40. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues. Obulesu M; Rao DM Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]